NCT00568750 2019-06-17
Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors
Swiss Cancer Institute
Phase 2 Completed
Clinical Trials
3 trialsNCT01643278 2017-01-10
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
National Cancer Institute (NCI)
Phase 1 Completed
NCT02776878 2016-05-18
A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
Peking University Cancer Hospital & Institute
Phase NA Unknown